Shift in motor-state equilibrium explains gait therapy effects of apomorphine in experimental Parkinsonism.

Saved in:
Bibliographic Details
Title: Shift in motor-state equilibrium explains gait therapy effects of apomorphine in experimental Parkinsonism.
Authors: Kabaoglu B; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Garulli EL; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., De Sa R; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Vogt A; Neuroscience Research Center (NWFZ), Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Behrsing R; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Skrobot M; Berlin Institute of Health Julius Wolff Institut - Center for Musculoskeletal Biomechanics and Regeneration, Charité - Universitätsmedizin Berlin, Luisenstraße 65, 10115 Berlin, Germany., Paulat R; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Pollak P; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Guldin LS; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Gerster M; Research Group Neural Interactions and Dynamics, Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany; Neurophysics Group, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Bernstein Center for Computational Neuroscience, Berlin, Germany., Neumann WJ; Movement Disorders and Neuromodulation Section, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Endres M; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Germany; DZHK (German Center for Cardiovascular Research), Berlin Site, Germany; DZNE (German Center for Neurodegenerative Disease), Berlin Site, Germany; DZPG (German Center of Mental Health), Berlin Site, Germany., Harms C; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Germany; DZHK (German Center for Cardiovascular Research), Berlin Site, Germany., Wenger N; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: nikolaus.wenger@charite.de.
Source: Experimental neurology [Exp Neurol] 2026 Jul; Vol. 401, pp. 115704. Date of Electronic Publication: 2026 Feb 27.
Publication Type: Journal Article
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2430 (Electronic) Linking ISSN: 00144886 NLM ISO Abbreviation: Exp Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1090-2430
DOI:10.1016/j.expneurol.2026.115704